FDA-approved Drug Makes Established Cancer Vaccine Work Better, Penn Study Finds Penn: Office of University Communications A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 ... |
